# TraceMap Kiro Review Packet

Status: not-started
Readiness: ready-for-implementation
Public claim level: concept

Review the `site-tracemap-tools-review-claim-checklist` spec for spec-review
findings first. This is a spec-only public site phase; it should not implement
site code.

## Review Orientation

Branch: codex/spec-site-review-claim-checklist
Last verified: 2026-06-18
Public claim level: concept
Prior review cycle: prior Opus and Sonnet spec reviews are recorded in
`implementation-state.md`; Medium findings were patched and re-reviewed.

## Scope

The future page or section should define a public-safe reviewer checklist that
turns TraceMap's claim boundary into a practical review ritual. Before a public
claim or internal review statement is repeated, a reviewer should check claim
level, proof path, rule ID or rule family, evidence tier, coverage label,
limitations, non-claims, source branch or main-dev status, and owner follow-up.

Please inspect:

- `.kiro/specs/site-tracemap-tools-review-claim-checklist/requirements.md`
- `.kiro/specs/site-tracemap-tools-review-claim-checklist/tasks.md`
- `.kiro/specs/site-tracemap-tools-review-claim-checklist/implementation-state.md`
- `.kiro/specs/site-tracemap-tools-review-claim-checklist/review-packet.md`

Review focus:

- Does the spec satisfy the requested spec-only scope without requiring site
  code changes in this phase?
- Are `Status: not-started`, `Readiness: ready-for-implementation`, and
  `Public claim level: concept` present and consistent?
- Are future implementation tasks unchecked?
- Does the checklist require claim level, proof path, rule ID or rule family,
  evidence tier, coverage label, limitations, non-claims, source branch or
  main-dev status, owner follow-up, reviewer, review date, and decision?
- Does the spec keep public claim levels bounded to `shipped`, `demo`,
  `concept`, and `hidden`?
- Does the spec force differentiation and cross-links with review room,
  manager FAQ, proof path index, and claim ledger or roadmap claim-ledger
  surfaces without duplicating them blindly?
- Does the spec keep the public claim level at concept unless a future spec
  amendment proves demo-level public support?
- Does the spec forbid claims that TraceMap proves runtime behavior,
  production traffic, endpoint performance, outage cause, release safety,
  operational safety, AI impact analysis, LLM analysis, or complete product
  coverage?
- Does the spec prevent raw facts, raw SQLite indexes, analyzer logs, raw
  source snippets, raw SQL, config values, secrets, local absolute paths, raw
  remotes, generated scan directories, and private sample names from becoming
  public page content?
- Does the spec avoid turning a checklist outcome into an unsupported impact,
  safety, release, root-cause, or production claim?
- Does validation cover discovery metadata, required links, forbidden copy,
  private-path checks, and implementation-state updates?

Return findings first, severity ordered. Include suggested spec edits for any
Medium or higher findings.
